- Home
- CANF vs PMNT Comparison
CANF vs PMNT Comparison
Compare CANF & PMNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CANF
- PMNT
- Stock Information
- Founded
- CANF 1994
- PMNT 1984
- Country
- CANF Israel
- PMNT United Kingdom
- Employees
- CANF N/A
- PMNT N/A
- Industry
- CANF Biotechnology: Pharmaceutical Preparations
- PMNT
- Sector
- CANF Health Care
- PMNT
- Exchange
- CANF Nasdaq
- PMNT NYSE
- Market Cap
- CANF 9.4M
- PMNT 11.2M
- IPO Year
- CANF N/A
- PMNT 2024
- Fundamental
- Price
- CANF $1.81
- PMNT $1.01
- Analyst Decision
- CANF Strong Buy
- PMNT Strong Buy
- Analyst Count
- CANF 2
- PMNT 1
- Target Price
- CANF $14.00
- PMNT $6.00
- AVG Volume (30 Days)
- CANF 122.9K
- PMNT 443.6K
- Earning Date
- CANF 03-04-2025
- PMNT 02-14-2025
- Dividend Yield
- CANF N/A
- PMNT N/A
- EPS Growth
- CANF N/A
- PMNT N/A
- EPS
- CANF N/A
- PMNT N/A
- Revenue
- CANF $667,000.00
- PMNT $21,307,000.00
- Revenue This Year
- CANF $409.56
- PMNT $3.91
- Revenue Next Year
- CANF N/A
- PMNT $29.32
- P/E Ratio
- CANF N/A
- PMNT N/A
- Revenue Growth
- CANF N/A
- PMNT N/A
- 52 Week Low
- CANF $1.29
- PMNT $0.66
- 52 Week High
- CANF $4.69
- PMNT $5.35
- Technical
- Relative Strength Index (RSI)
- CANF 64.57
- PMNT N/A
- Support Level
- CANF $1.45
- PMNT N/A
- Resistance Level
- CANF $1.50
- PMNT N/A
- Average True Range (ATR)
- CANF 0.12
- PMNT 0.00
- MACD
- CANF 0.05
- PMNT 0.00
- Stochastic Oscillator
- CANF 66.67
- PMNT 0.00
About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)
Can Fite Biofarma Ltd is an clinical-stage biopharmaceutical company. The company develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases. The company's platform technology utilizes the Gi protein associated A3 adenosine receptor, or A3AR, as a therapeutic target. The company's drug candidate, Piclidenoson, is currently in a Phase III trial for psoriasis. Can-Fite's liver drug, Namodenoson, is headed into a Phase III trial for hepatocellular carcinoma (HCC), the common form of liver cancer, and a Phase IIb trial for the treatment of non-alcoholic steatohepatitis (NASH).
About PMNT PERFECT MOMENT LTD
Perfect Moment Ltd is a company which is a luxury lifestyle brand that combines fashion and technical performance for its ranges of skiwear, outerwear, swimwear, and activewear. It operates at the intersection of luxury fashion and multi-channel commerce. Although the Company is organized fundamentally as one business segment which is product sales, the Company's revenues are primarily split between three geographic areas which are the U. S., Europe, and the UK.